By Dr Anitha Karunairajah, Breast Surgeon, Joondalup
Breast cancer remains one of the most prevalent cancers worldwide, affecting around one in seven women and ranking as the second most common cause of cancer-related death among females.
However, the landscape of breast cancer treatment is evolving rapidly, bringing improved survival rates and better quality of life for patients.
One of the most significant advancements in breast cancer care is the move towards personalised treatment. Tumour profiling and precision medicine now allow for therapies tailored to the individual patient’s tumour biology, reducing treatment toxicity while improving efficacy, leading...
Breast cancer remains one of the most prevalent cancers worldwide, affecting around one in seven women and ranking as the second most common cause of cancer-related death among females.
However, the landscape of breast cancer treatment is evolving rapidly, bringing improved survival rates and better quality of life for patients.
One of the most significant advancements in breast cancer care is the move towards personalised treatment. Tumour profiling and precision medicine now allow for therapies tailored to the individual patient’s tumour biology, reducing treatment toxicity while improving efficacy, leading...
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.